Shandong Wohua Pharmaceutical Co Ltd (002107) - Total Assets

Latest as of December 2025: CN¥977.37 Million CNY ≈ $143.02 Million USD

Based on the latest financial reports, Shandong Wohua Pharmaceutical Co Ltd (002107) holds total assets worth CN¥977.37 Million CNY (≈ $143.02 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Shandong Wohua Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Shandong Wohua Pharmaceutical Co Ltd - Total Assets Trend (2003–2025)

This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.

Shandong Wohua Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Shandong Wohua Pharmaceutical Co Ltd's total assets of CN¥977.37 Million consist of 58.0% current assets and 42.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	40.4%
Accounts Receivable	CN¥67.13 Million	6.9%
Inventory	CN¥93.46 Million	9.6%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥34.34 Million	3.5%
Goodwill	CN¥32.51 Million	3.3%

Asset Composition Trend (2003–2025)

This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 002107 company net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Shandong Wohua Pharmaceutical Co Ltd's current assets represent 58.0% of total assets in 2025, a decrease from 59.6% in 2003.
Cash Position: Cash and equivalents constituted 40.4% of total assets in 2025, up from 24.8% in 2003.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 14.0% in 2003.
Asset Diversification: The largest asset category is inventory at 9.6% of total assets.

Shandong Wohua Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Shandong Wohua Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
China SXT Pharmaceuticals Inc NASDAQ:SXTC	USA	$26.35 Million
DHG Pharmaceutical JSC VN:DHG	Vietnam	₫5.17 Trillion
Caring Brands, Inc. Common Stock NASDAQ:CABR	USA	$2.33 Million
Akanda Corp NASDAQ:AKAN	USA	$6.22 Million
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Painreform Ltd NASDAQ:PRFX	USA	$11.16 Million
Galderma Group N SW:GALD	Switzerland	CHF12.88 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥10.21 Billion

Shandong Wohua Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.35	2.24	2.11
Quick Ratio	1.97	1.80	1.79
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥326.04 Million	CN¥300.83 Million	CN¥422.57 Million

Shandong Wohua Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Shandong Wohua Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	5.73
Latest Market Cap to Assets Ratio	0.59
Asset Growth Rate (YoY)	-0.8%
Total Assets	CN¥977.37 Million
Market Capitalization	$573.51 Million USD

Valuation Analysis

Below Book Valuation: The market values Shandong Wohua Pharmaceutical Co Ltd's assets below their book value (0.59x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Shandong Wohua Pharmaceutical Co Ltd's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual total assets of Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥977.37 Million ≈ $143.02 Million	-0.85%
2024-12-31	CN¥985.73 Million ≈ $144.24 Million	-13.89%
2023-12-31	CN¥1.14 Billion ≈ $167.51 Million	+4.07%
2022-12-31	CN¥1.10 Billion ≈ $160.96 Million	-5.26%
2021-12-31	CN¥1.16 Billion ≈ $169.90 Million	-15.25%
2020-12-31	CN¥1.37 Billion ≈ $200.49 Million	+35.92%
2019-12-31	CN¥1.01 Billion ≈ $147.51 Million	+9.29%
2018-12-31	CN¥922.38 Million ≈ $134.97 Million	+7.82%
2017-12-31	CN¥855.50 Million ≈ $125.19 Million	+21.24%
2016-12-31	CN¥705.63 Million ≈ $103.26 Million	+5.60%
2015-12-31	CN¥668.23 Million ≈ $97.78 Million	-0.06%
2014-12-31	CN¥668.64 Million ≈ $97.84 Million	+3.66%
2013-12-31	CN¥645.05 Million ≈ $94.39 Million	+0.21%
2012-12-31	CN¥643.70 Million ≈ $94.19 Million	+3.43%
2011-12-31	CN¥622.35 Million ≈ $91.07 Million	-2.17%
2010-12-31	CN¥636.14 Million ≈ $93.09 Million	-17.80%
2009-12-31	CN¥773.86 Million ≈ $113.24 Million	+8.67%
2008-12-31	CN¥712.11 Million ≈ $104.20 Million	+57.36%
2007-12-31	CN¥452.54 Million ≈ $66.22 Million	+90.93%
2006-12-31	CN¥237.01 Million ≈ $34.68 Million	+21.58%
2005-12-31	CN¥194.94 Million ≈ $28.53 Million	+27.48%
2004-12-31	CN¥152.92 Million ≈ $22.38 Million	+13.30%
2003-12-31	CN¥134.97 Million ≈ $19.75 Million	--

About Shandong Wohua Pharmaceutical Co Ltd

SHE:002107 China Drug Manufacturers - Specialty & Generic

Market Cap

$573.51 Million

CN¥3.92 Billion CNY

Market Cap Rank

#11926 Global

#3607 in China

Share Price

CN¥6.79

Change (1 day)

+1.80%

52-Week Range

CN¥5.47 - CN¥8.11

All Time High

CN¥17.57